I live in asia and spent all day looking through some stocks that came up on a screen. Many, many of them were these zero profit, oftentimes zero revenue, pie-in-the-sky, rinky-dink biotech firms.
Now I don't know squat about biotech or how the sector is traditionally valued, but most of the small companies I looked at today seemed extremely overvalued - already up 3,4, 500% YTD, and burning cash quickly.
Yet, MRK may have already fallen to attractive levels. Perhaps its a case of Buy MRK/ PFE, sell the rest ... After all, MRK/PFE will likely acquire the promising ones and let the rest fail, no?